Blog
Agilent’s Latest Acquisition in the Cell Analysis Space: BioTek Instruments
BlogAgilent Technologies Inc. recently announced it had signed an agreement to acquire BioTek Instruments, a global leader in life science instrumentation.
Read More
Therapeutically Targeting DYRK1A in Alzheimer’s Disease
BlogAlzheimer’s disease (AD) is a neurodegenerative condition. There are currently no FDA-approved disease‐modifying therapies for AD, despite it being the most common cause of dementia. We recently spoke with Samumed’s CEO Osman Kibar, to learn more about the company's efforts to therapeutically target "DYRK1A" in AD.
Read More
A Step Towards Democratization in Mass Spectrometry: Agilent Launch Novel "Self-aware" Mass Detector
BlogHow can vendors ensure their technologies are less complex, and therefore available to a wider range of users, without compromising on the quality of data?
Read More
Advancing Robotic and Automation Technologies to Improve Human Health
BlogRobotic and automation technologies are advancing at a staggering rate, and the introduction of collaborative robots has fundamentally changed the way scientists coexist with automated systems.. Ira Hoffman, CEO at HighRes Biosolutions® tells us about the company’s mission to “improve human health through life science robotics”.
Read More
Maximizing Drug Discovery Success With Machine Learning
BlogThe pipeline to new drugs isn’t straightforward, but pharmas can pool their data resources to speed things up. The MELLODDY consortium hopes to make data sharing simple and secure. We talked to Hugo Ceulemans, MELLODDY Project Leader and Mathieu Galtier, Project Coordinator at Owkin to find out more.
Read More
Imagine Collaboration, Without the Faff
BlogImagine if there was a better way to write, format, and review scientific manuscripts for publication. doDOC Document Collaboration Expert Leif Måsvær believes there is. Leif explains how this cloud-based platform is a game-changer that overcomes the major obstacles present during the authoring, writing, and reviewing process.
Read More
Screening Living Cells at High Speed
BlogWe recently spoke with Eric Hobbs, CEO at Berkeley Lights to learn more about "digital cell biology". Eric also describes how optofluidics can be used to gain fast, comprehensive measurements and insights across thousands of cells in parallel.
Read More
Uniting Stakeholders to Streamline Drug Discovery
BlogWe recently spoke with Tyler Golato, Lead Scientist at Molecule, to learn more about the "innovation crisis", the factors directly impacting the types of therapeutics being brought to market, and how by uniting stakeholders it is possible to streamline the drug development pipeline.
Read More
Overcoming the Data Analysis Bottleneck in High-throughput Chemistry
BlogWhilst some aspects of biochemistry research have become increasingly high-throughput, other, like analysis of chemical data, are too often laborious and slow. We talked to Andrew Anderson, Vice President of Innovation and Informatics Strategy at ACD/Labs about how the field is being changed by automation and how Katalyst hopes to speed up pharmaceutical development.
Read More
Zika vs Dengue: Minimizing Cross-reactivity in Immunoassay Development
BlogThe Zika virus poses a significant global risk, and there is currently no vaccine or specific treatment available for those infected. Having access to sensitive and specific diagnostic assays is essential to disease management, and in enabling effective research and the development of therapeutics. We spoke to Nick Roesen, Founder and COO of The Native Antigen Company, to learn about the Zika virus immunoassays that have been developed to overcome cross-reactivity with Dengue.
Read More
